advanced search

BOTU

The Buchanan Ocular Therapeutics Unit conducts scientific research into new treatments – be they pharmaceutical-, cell- or technology-based – for eye diseases (ocular therapeutics). Research focuses on developing drug-releasing implants for the eye and evaluating new treatments.


Headquarters
University of Auckland
Private Bag 92019
Auckland 1142
New Zealand

Phone / Contact

T: +64 9 923 6386

Articles by BOTU

EARLY INSIGHT
Frazer P Coutinho
TARGETING DRUGS TO DISEASED OCULAR CELLS
Frazer Coutinho, Colin Green and Ilva Rupenthal discuss the targeted delivery of ocular therapeutics to diseased cells, using the cell-penetrating peptide, Xentry.
EXPERT VIEW
Di Huang
USING PHYSICAL FORCES TO ENHANCE OCULAR DRUG DELIVERY
Di Huang, Erica Chen and Ilva Rupenthal discuss the possibilities offered by physical force-based methods of enhancing the efficacy of ophthalmic drug delivery by providing a way past the eye’s natural barriers.
EXPERT VIEW
Dr Ilva D Rupenthal
OCULAR DRUG DELIVERY TECHNOLOGIES: EXCITING TIMES AHEAD
Ilva Rupenthal gives a sector overview of the occular drug delivery space.
Top

W3 Total Cache is currently running in Pro version Development mode.